Investigational drug · Phase 3
CS-001
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Canities, Grey Hair.
Phase 3Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "CS-001"
First trial start
2027
Jun 15, 2027
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "CS-001", any sponsor or status.
Conditions studied
As listed on its trial records.
- Canities
- Grey Hair
Largest trials
Live from ClinicalTrials.gov: studies naming "CS-001" as an intervention, largest first.
- Clinical Study of CS-001 as a Treatment for Canities (Grey Hair)Pivotal-lookingNot yet recruiting
Applied Biology, Inc.Industry
NCT06745336 · 240 participants (planned) · Start Jun 15, 2027 · Primary completion Dec 15, 2027
Drug: CS-001; Placebo Topical Solution · For: Canities; Grey Hair
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Canities
- CS-002Phase 21 trial
Applied Biology, Inc. · Canities, Grey Hair
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.